Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 262

1.

The effectiveness of Kinesio Taping® for pain management in knee osteoarthritis: a randomized, double-blind, controlled clinical trial.

Donec V, Kubilius R.

Ther Adv Musculoskelet Dis. 2019 Aug 29;11:1759720X19869135. doi: 10.1177/1759720X19869135. eCollection 2019.

2.

When rheumatology and infectious disease come together.

Fragoulis GE, Sipsas NV.

Ther Adv Musculoskelet Dis. 2019 Aug 22;11:1759720X19868901. doi: 10.1177/1759720X19868901. eCollection 2019. No abstract available.

3.

Therapeutic approaches to osteosarcopenia: insights for the clinician.

Fatima M, Brennan-Olsen SL, Duque G.

Ther Adv Musculoskelet Dis. 2019 Aug 7;11:1759720X19867009. doi: 10.1177/1759720X19867009. eCollection 2019. Review.

4.

The role of microbiome in rheumatoid arthritis treatment.

Bodkhe R, Balakrishnan B, Taneja V.

Ther Adv Musculoskelet Dis. 2019 Jul 30;11:1759720X19844632. doi: 10.1177/1759720X19844632. eCollection 2019. Review.

5.

Update on the management of hypophosphatasia.

Choida V, Bubbear JS.

Ther Adv Musculoskelet Dis. 2019 Aug 1;11:1759720X19863997. doi: 10.1177/1759720X19863997. eCollection 2019. Review.

6.

Update on novel pharmacological therapies for osteoarthritis.

Ghouri A, Conaghan PG.

Ther Adv Musculoskelet Dis. 2019 Jul 23;11:1759720X19864492. doi: 10.1177/1759720X19864492. eCollection 2019. Review.

7.

Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysis.

Hayashi K, Ohashi K, Watanabe H, Sada KE, Shidahara K, Asano Y, Asano SH, Yamamura Y, Miyawaki Y, Morishita M, Matsumoto Y, Kawabata T, Wada J.

Ther Adv Musculoskelet Dis. 2019 Jul 18;11:1759720X19864822. doi: 10.1177/1759720X19864822. eCollection 2019.

8.

Helpful, albeit hazardous! Esophageal stem-cell injection in systemic sclerosis.

Durchschein F, Moazedi-Fuerst F, Kielhauser S, Lackner A, Wiedner M, Koch H, Justich I, Eherer A.

Ther Adv Musculoskelet Dis. 2019 Jul 16;11:1759720X19863618. doi: 10.1177/1759720X19863618. eCollection 2019.

9.

Does periodontitis represent a risk factor for rheumatoid arthritis? A systematic review and meta-analysis.

de Oliveira Ferreira R, de Brito Silva R, Magno MB, Carvalho Almeida APCPS, Fagundes NCF, Maia LC, Lima RR.

Ther Adv Musculoskelet Dis. 2019 Jul 9;11:1759720X19858514. doi: 10.1177/1759720X19858514. eCollection 2019. Review.

10.

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis.

Elliott A, Wright G.

Ther Adv Musculoskelet Dis. 2019 Jun 19;11:1759720X19858510. doi: 10.1177/1759720X19858510. eCollection 2019. No abstract available.

11.

Functional risk for fracture by safe functional motion testing: a short version of the safe functional motion test.

Recknor CP, Van Dussen D, MacIntyre N, Recknor J.

Ther Adv Musculoskelet Dis. 2019 Jun 24;11:1759720X19856012. doi: 10.1177/1759720X19856012. eCollection 2019.

12.

Is there a role for cherries in the management of gout?

Collins MW, Saag KG, Singh JA.

Ther Adv Musculoskelet Dis. 2019 May 17;11:1759720X19847018. doi: 10.1177/1759720X19847018. eCollection 2019. Review.

13.

Corticosteroid injections for knee osteoarthritis are supported by the literature: in the affirmative.

Piuzzi NS, Mont MA.

Ther Adv Musculoskelet Dis. 2019 Apr 26;11:1759720X19847023. doi: 10.1177/1759720X19847023. eCollection 2019. No abstract available.

14.

Recent developments in advanced imaging in gout.

Davies J, Riede P, van Langevelde K, Teh J.

Ther Adv Musculoskelet Dis. 2019 Apr 16;11:1759720X19844429. doi: 10.1177/1759720X19844429. eCollection 2019. Review.

15.

New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review.

Del Giorno R, Iodice A, Mangas C, Gabutti L.

Ther Adv Musculoskelet Dis. 2019 Apr 12;11:1759720X19841796. doi: 10.1177/1759720X19841796. eCollection 2019.

16.

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study.

Bessette L, Haraoui B, Chow A, Fortin I, Dixit S, Khraishi M, Haaland D, Elmoufti S, Staelens F, Bogatyreva I, Syrotuik J, Shaikh S.

Ther Adv Musculoskelet Dis. 2019 Mar 5;11:1759720X19831151. doi: 10.1177/1759720X19831151. eCollection 2019.

17.

Serum chitotriosidase and neopterin levels in patients with ankylosing spondylitis.

Yavuz F, Kesikburun B, Öztürk Ö, Güzelküçük Ü.

Ther Adv Musculoskelet Dis. 2019 Mar 1;11:1759720X19832321. doi: 10.1177/1759720X19832321. eCollection 2019.

18.

IL-12/IL-23p40 identified as a downstream target of apremilast in ex vivo models of arthritis.

Kragstrup TW, Adams M, Lomholt S, Nielsen MA, Heftdal LD, Schafer P, Deleuran B.

Ther Adv Musculoskelet Dis. 2019 Feb 22;11:1759720X19828669. doi: 10.1177/1759720X19828669. eCollection 2019.

19.

Health effects of direct triaging to physiotherapists in primary care for patients with musculoskeletal disorders: a pragmatic randomized controlled trial.

Bornhöft L, Larsson ME, Nordeman L, Eggertsen R, Thorn J.

Ther Adv Musculoskelet Dis. 2019 Feb 15;11:1759720X19827504. doi: 10.1177/1759720X19827504. eCollection 2019.

20.

Current advances in the treatment of giant cell arteritis: the role of biologics.

Low C, Conway R.

Ther Adv Musculoskelet Dis. 2019 Feb 13;11:1759720X19827222. doi: 10.1177/1759720X19827222. eCollection 2019. Review.

Supplemental Content

Loading ...
Support Center